Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

iShares Microcap ETF (NY:IWC)

193.24 +1.33 (+0.69%)
Streaming Delayed Price Updated: 3:37 PM EDT, May 28, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about iShares Microcap ETF

< Previous 1 2 3 4 5 Next >
News headline image
Palladyne AI Subsidiary Wins US Navy Contract For Developing New Missiles — PDYN Stock Soars Pre-Market ↗
The company said that the Air-Launched Rapid Response Missile is expected to deliver nearly hypersonic speed and long range at a fraction of the cost of other hypersonic weapons. 
Via Stocktwits
Topics Artificial Intelligence Economy
News headline image
Why Is GLSI Stock Rising Today? ↗
Greenwich LifeSciences said its Phase III breast cancer immunotherapy trial, involving 250 patients, showed a recurrence rate of under 1% per year. 
Via Stocktwits
Topics Economy Government
News headline image
RILY Stock Rallies After-Hours – How Much Of Its Debt Is Reduced By Latest Senior Note Transactions? ↗
The company said upon closing of the final transaction with an institutional investor its outstanding debt will be reduced by approximately $37.9 million. 
Via Stocktwits
Topics Earnings
News headline image
FreightCar America Slumps 21% As Q4 Results And FY26 Disappoints Investors ↗
The company said its revenues in Q4 came at $125.6 million, lower than $137.7 million in the fourth quarter of 2024, despite railcar deliveries of 1,172 units compared to 1,019 units in the prior year... 
Via Stocktwits
INMB Stock Rises Pre-Market – What Did The FDA Say About Its Alzheimer’s Trial? ↗
Via Stocktwits
Why Did MAXN Stock Surge 19% In Pre-Market Today? ↗
Via Stocktwits
Why Is MAMO Stock Falling Pre-Market Today? ↗
Via Stocktwits
News headline image
ANTX Stock Records Biggest Ever Single Day Gain, Surges 500% Over Past Four Sessions – What Triggered This Smashing Rally? ↗
AN2 Therapeutics shares more than doubled in value on Monday after the company announced a private placement to raise about $40 million. 
Via Stocktwits
News headline image
BNAI Stock Rockets 140% In 8 Days — Retail Traders Now Smell A Short Squeeze ↗
Recent expansion updates, a surge in retail interest, and a low stock float appear to be powering the stock. 
Via Stocktwits
Topics Artificial Intelligence
News headline image
Owlet Stock Is Down 26% After Hours – How Did The Company’s Q4 Results Fare? ↗
Owlet said that for the first quarter of 2026, it expects revenue in the range of $20 to $21 million. The forecast was significantly lower than Wall Street expectations of $26.2 million. 
Via Stocktwits
News headline image
Palladyne AI CEO Touts Expanded Backlog, Deeper Defense Engagement After Q4 Beat Sends PDYN Stock Soaring ↗
Palladyne AI reported a loss of $0.04 per share, down from a loss of $1.75 per share during the same quarter a year ago, and better than Wall Street’s expectations of a loss of $0.14 per share. 
Via Stocktwits
Topics Artificial Intelligence Stocks
News headline image
FARM Stock Sinks To 48-Year Lows – What Triggered The Collapse? ↗
The company announced an agreement to be acquired by Royal Cup Coffee & Tea in an all-cash deal valued at $1.29 per share. 
Via Stocktwits
Topics Bankruptcy
News headline image
Why Did CDXS Stock Jump 7% Today? ↗
The company tied up with an innovator pharmaceutical company to manufacture 50 grams of small interfering RNA using a proprietary ECO Synthesis platform. 
Via Stocktwits
News headline image
BBAI Stock Slides 8% – Analyst Flags Soft Sales Estimate, Retail Expects A Further 50% Slump In Share Price ↗
Brokerages cut the stock’s price target after the company reported a 38% decline in fourth-quarter revenue. 
Via Stocktwits
Topics Artificial Intelligence
News headline image
TBPH Stock Slumps 30%, Falls Below 200-DMA For First Time In Over 9 Months As Phase 3 Study Misses Primary Endpoint ↗
The company reported that its Phase 3 CYPRESS study of ampreloxetine in patients with hypotension failed to meet its primary endpoint. 
Via Stocktwits
Topics Workforce
News headline image
AARD Stock Slumps 54% Pre-Market – Here’s Why Analysts Are Not ‘Comfortable’ With The Suspension Of A Key Phase 3 Trial ↗
Aardvark Therapeutics shares saw brokerage downgrades after the company paused its Phase 3 trial to treat hyperphagia in patients with Prader-Willi syndrome. 
Via Stocktwits
News headline image
KORE Stock Is Ripping Pre-Market Today After Company Agrees To A Deal To Take It Private ↗
KORE stated that Searchlight and Abry will acquire all shares of the company’s issued and outstanding common stock that they currently don’t own in an all-cash transaction valued at nearly $726... 
Via Stocktwits
News headline image
Why Did NGNE Stock Surge 25% In Pre-Market Today? ↗
The company said that the U.S. Food and Drug Administration granted a key designation for its investigational gene therapy targeting Rett syndrome. 
Via Stocktwits
News headline image
CIFR Stock Is Gaining Retail Attention After Earnings Despite Revenue Miss – Here’s What Investors Are Watching ↗
Cipher’s fourth-quarter revenue came in at $60 million, significantly below the consensus estimates of $85.7 million, according to Fiscal.ai data. 
Via Stocktwits
Topics Bonds
News headline image
Why Did PVLA Stock Surge 45% In Pre-Market Today? ↗
The biotech company reported statistically significant Phase 3 data for QTORIN gel. 
Via Stocktwits
News headline image
ATOM Stock Is Falling Pre-Market Today After Atomera Announces Stock Offering At A Deep Discount ↗
The company announced on Monday that it has entered into a definitive agreement to sell 5 million shares of its common stock at an offering price of $5 per share. 
Via Stocktwits
News headline image
Hycroft Mining Stock Is Rallying Today – What Is Driving Trader Sentiment? ↗
The company said that it has filed a third-party, independent Technical Report updating its Mineral Resource estimate with an effective date of January 21, 2026. 
Via Stocktwits
News headline image
Why Is Cineverse Stock Rising Despite Missing Q3 Revenue and Earnings Estimates? ↗
The company said it expects $115 million to $120 million in revenue for fiscal year 2027, however analysts on average were expecting the revenue of $85.23 million, as per data from fiscal.ai. 
Via Stocktwits
News headline image
CNVS Stock Surged 20% Today, Breaching 100-DMA For First Time Since August – Here’s What Triggered The Rally ↗
The company announced the acquisition of ad-tech firm IndiCue for up to $40 million in total consideration. 
Via Stocktwits
Topics Economy
News headline image
BURU Stock Set To Open At Record Low After Pricing Of Public Offering – Retail Signals Further Downside ↗
The company announced pricing for a $12 million public offering at an 8% discount to Thursday’s close. 
Via Stocktwits
News headline image
MCRB Stock Declines As Seres Therapeutics Pauses SER-155 Phase 2 Study And Shrinks Headcount By 30% ↗
The company said that it will continue to seek funding for the SER-155 Phase 2 study. 
Via Stocktwits
News headline image
Why Is QNCX Stock Up 60% Pre-Market After A Near-Total Wipeout? ↗
The company announced that it has appointed LifeSci Capital as its exclusive financial advisor to support a restructuring effort and review strategic alternatives. 
Via Stocktwits
News headline image
HUMA Stock Just Shot Up 12% Today – Here’s Everything To Know About The DOD Funding Fueling The Surge ↗
The company stated that its product, Symvess, is the only human-derived bioengineered blood vessel approved by the U.S. Food and Drug Administration. 
Via Stocktwits
News headline image
Why Did PDYN Stock Pop Over 10% In Pre-Market Today? ↗
The company signed an agreement with a major U.S. defense prime contractor to supply a subsystem that supports missile propulsion. 
Via Stocktwits
Topics Artificial Intelligence
News headline image
Why Did AQST Stock Jump 35% Today? ↗
The company received a Complete Response Letter from the U.S. Food and Drug Administration for its New Drug Application seeking approval of Anaphylm, a sublingual film to treat severe Type I allergic... 
Via Stocktwits
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.